BioCentury
ARTICLE | Clinical News

SuliXen: Phase I started

February 4, 2008 8:00 AM UTC

Lipoxen began a Russian Phase I trial in 12 healthy volunteers to compare 0.11 U/kg and 0.31 U/kg SuliXen vs. 0.21 U/kg Lantus insulin glargine from sanofi-aventis Group (Euronext:SAN; NYSE:SNY, Par...